Fig. 4 | Scientific Reports

Fig. 4

From: Prognostic model of lung adenocarcinoma from the perspective of cancer-associated fibroblasts using single-cell and bulk RNA-sequencing

Fig. 4

Prognostic ability of MyCAFs and ImmCAFs explored via digital cytometry. (A) Grouping of LUAD samples based on the median relative abundance of ImmCAFs. (B) Exploration of the prognostic value of ImmCAFs via survival analysis. (C) Grouping of LUAD samples based on the median relative abundance of MyCAFs. (D) Exploration of the prognostic value of MyCAFs in LUAD via survival analysis. TCGA The Cancer Genome Atlas, LUAD lung adenocarcinoma, MyCAFs myofibroblastic cancer-associated fibroblasts, ImmCAFs immune-related cancer-associated fibroblasts. P < 0.05, statistically significant differences.

Back to article page